1. Home
  2. SIBN vs BME Comparison

SIBN vs BME Comparison

Compare SIBN & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SIBN
  • BME
  • Stock Information
  • Founded
  • SIBN 2008
  • BME 2005
  • Country
  • SIBN United States
  • BME United States
  • Employees
  • SIBN N/A
  • BME N/A
  • Industry
  • SIBN Medical/Dental Instruments
  • BME Trusts Except Educational Religious and Charitable
  • Sector
  • SIBN Health Care
  • BME Finance
  • Exchange
  • SIBN Nasdaq
  • BME Nasdaq
  • Market Cap
  • SIBN 571.0M
  • BME 462.3M
  • IPO Year
  • SIBN 2018
  • BME N/A
  • Fundamental
  • Price
  • SIBN $18.78
  • BME $36.19
  • Analyst Decision
  • SIBN Strong Buy
  • BME
  • Analyst Count
  • SIBN 5
  • BME 0
  • Target Price
  • SIBN $24.40
  • BME N/A
  • AVG Volume (30 Days)
  • SIBN 597.2K
  • BME 34.0K
  • Earning Date
  • SIBN 05-05-2025
  • BME 01-01-0001
  • Dividend Yield
  • SIBN N/A
  • BME 6.26%
  • EPS Growth
  • SIBN N/A
  • BME N/A
  • EPS
  • SIBN N/A
  • BME 1.44
  • Revenue
  • SIBN $176,601,000.00
  • BME N/A
  • Revenue This Year
  • SIBN $19.30
  • BME N/A
  • Revenue Next Year
  • SIBN $15.28
  • BME N/A
  • P/E Ratio
  • SIBN N/A
  • BME $28.37
  • Revenue Growth
  • SIBN 22.60
  • BME N/A
  • 52 Week Low
  • SIBN $11.70
  • BME $35.53
  • 52 Week High
  • SIBN $20.05
  • BME $43.20
  • Technical
  • Relative Strength Index (RSI)
  • SIBN 60.13
  • BME 49.92
  • Support Level
  • SIBN $18.25
  • BME $35.46
  • Resistance Level
  • SIBN $19.09
  • BME $35.99
  • Average True Range (ATR)
  • SIBN 0.57
  • BME 0.49
  • MACD
  • SIBN -0.15
  • BME 0.06
  • Stochastic Oscillator
  • SIBN 26.96
  • BME 74.56

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About BME Blackrock Health Sciences Trust

Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.

Share on Social Networks: